HOME | Alphawatch

top of page

HOME
BLOG
ABOUT
More

Use tab to navigate through the menu items.

Stock Exchange

SIGN UP & STAY UPDATED!

Thanks for submitting!

March 2025 Riffin' on Real Estate

Jonathan Poyer

4 days ago1 min read

March 2025 Riffin' on Real Estate

Medicare Advantage Rates Set to Increase. CVS Among Others Benefitting

Jonathan Poyer

Mar 62 min read

Medicare Advantage Rates Set to Increase. CVS Among Others Benefitting

2 MedTech IPOs as KMTS and ADVB List to the NASDAQ. JAZZ Announces Acquisition of Chimerix for $935M

Jonathan Poyer

Mar 61 min read

2 MedTech IPOs as KMTS and ADVB List to the NASDAQ. JAZZ Announces Acquisition of Chimerix for $935M

Meet the Manager: Anna Damato, PhD

Jonathan Poyer

Mar 64 min read

Meet the Manager: Anna Damato, PhD

Tariffs and Their Potential Impact on Medical Devices

Jonathan Poyer

Mar 62 min read

Tariffs and Their Potential Impact on Medical Devices

MedTech M&A Outpacing Biotech So Far in 2025. Novartis Acquires Anthos and Cosette Acquires Mayne

Jonathan Poyer

Feb 271 min read

MedTech M&A Outpacing Biotech So Far in 2025. Novartis Acquires Anthos and Cosette Acquires Mayne

Eli Lilly Changes to Zepbound and tirzepatide Should Broaden Access

Jonathan Poyer

Feb 261 min read

Eli Lilly Changes to Zepbound and tirzepatide Should Broaden Access

FDA, HIMS, and GLP-1 Drugs; Compounding GLP-1 No Longer Broadly Allowed. Look at LLY and NOVO.

Jonathan Poyer

Feb 251 min read

FDA, HIMS, and GLP-1 Drugs; Compounding GLP-1 No Longer Broadly Allowed. Look at LLY and NOVO.

Health Companies Using DeepSeek's AI Chatbot Hoping for an Edge

Jonathan Poyer

Feb 251 min read

Health Companies Using DeepSeek's AI Chatbot Hoping for an Edge

The Doctor is IN | February 2025

Jonathan Poyer

Feb 201 min read

The Doctor is IN | February 2025

February 2025 Riffin' on Real Estate

Jonathan Poyer

Feb 121 min read

February 2025 Riffin' on Real Estate

Novartis Enters the Acquisition Game Acquiring Anthos Therapeutics for $925M

Jonathan Poyer

Feb 122 min read

Novartis Enters the Acquisition Game Acquiring Anthos Therapeutics for $925M

© 2022 AlphaWatch

bottom of page